This content is machine translated Pain therapy with non-opioid analgesics Benefit-risk assessment and patient education In Switzerland, paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs) and metamizole are available as non-opioid analgesics. NSAIDs or metamizole should be considered if acetaminophen does not provide adequate pain relief. A differentiated…
View Post 5 min This content is machine translated Functional dyspepsia Consider phytotherapeutics as a therapeutic option Functional dyspepsia (FD) is a heterogeneous disorder in terms of both pathophysiology and symptomatology. Accordingly, there is hardly any intervention that is effective for all patients. In the context of…
View Post 13 min This content is machine translated Multiple sclerosis S1P receptor modulators in RRMS: tailored therapy management Modulation of S1P receptors is an important and interesting therapeutic target in the treatment management of multiple sclerosis due to their functional multifold. Currently, three S1P receptor modulators are available… CME-Test
View Post 3 min This content is machine translated Antidepressant monotherapy Trazodone with innovative galenics achieves rapid and significant response The antidepressant monotherapy with trazodone achieves an effective response after only one week with a single daily dose starting at 150 mg. The multifunctional antidepressant mechanism of action of the serotonin…
View Post 3 min This content is machine translated Multiple sclerosis Effective therapy management also protects brain volume Each year, a person loses about 0.2-0.4% of their brain volume. So far, so normal. In patients with multiple sclerosis, however, this value is about twice as high. This is due…
View Post 3 min This content is machine translated "Medication Overuse Headache" (MOH). What does the updated S1 guideline say? The 2022 updated guideline incorporates the latest recommendations of the International Headache Society as well as current study findings on drug interventions. Antibodies directed against CGRP or its receptor have…
View Post 4 min This content is machine translated Amendment of the Swiss Narcotics Law Cannabis medicines now usable without exceptional approval Interest in the medicinal use of cannabinoids has increased greatly in recent years due to their wide range of applications and numerous reports of successful treatments. As of August 1,…
View Post 9 min This content is machine translated Drug interactions Refresher – Do’s and dont’s at a glance Patients would make the title of this post more authoritative: Do my physicians safely protect me from avoidable risks due to inappropriate combination of drugs? This illustrates the standard to… CME-Test
View Post 3 min This content is machine translated Brain diseases Supply strategies discussed on an interdisciplinary basis Representatives from neurology, psychiatry and pharmacy met for the first time at the Berlin Brain Summit for an interdisciplinary summit on brain diseases. The aim of the inter-professional exchange was…
View Post 5 min This content is machine translated Pain therapy for rheumatic inflammatory diseases It doesn’t always have to be an opioid For patients with rheumatic diseases, pain is the central problem. However, recent studies show that influencing pain experience with biologics is possible and that JAK inhibitors can provide rapid, direct…
View Post 3 min This content is machine translated Vascular dementia Ginkgo biloba extract, cholinesterase inhibitor, or both? In a retrospective study, 12 months of treatment with a Ginkgo biloba special extract as monotherapy or in combination with cholinesterase inhibitors resulted in a reduction in cognitive and neuropsychiatric symptoms…
